Safety and Effectiveness Analysis of Dolutegravir and Dolutegravir/Abacavir/Lamivudine in Japanese People Living with HIV: 10 years of Post-Marketing Surveillance.
- DOI
- 10.1007/s12325-026-03544-0
- Published
- 2026 Jun
- Container
- Advances in therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-026-03544-0,
title = {Safety and Effectiveness Analysis of Dolutegravir and Dolutegravir/Abacavir/Lamivudine in Japanese People Living with HIV: 10 years of Post-Marketing Surveillance.},
author = {Sebata A and Nagao T and Matsukawa T and Maeno Y and Suzuki M and Yoshikawa Y and Ibe S and Fukuda A and Wang D},
year = {2026},
journal = {Advances in therapy},
doi = {10.1007/s12325-026-03544-0},
url = {https://doi.org/10.1007/s12325-026-03544-0}
}RIS
TY - JOUR TI - Safety and Effectiveness Analysis of Dolutegravir and Dolutegravir/Abacavir/Lamivudine in Japanese People Living with HIV: 10 years of Post-Marketing Surveillance. AU - Sebata A AU - Nagao T AU - Matsukawa T AU - Maeno Y AU - Suzuki M AU - Yoshikawa Y AU - Ibe S AU - Fukuda A AU - Wang D PY - 2026 JO - Advances in therapy DO - 10.1007/s12325-026-03544-0 UR - https://doi.org/10.1007/s12325-026-03544-0 ER -
APA
A, S., T, N., T, M., Y, M., M, S., Y, Y., S, I., A, F., & D, W. (2026). Safety and Effectiveness Analysis of Dolutegravir and Dolutegravir/Abacavir/Lamivudine in Japanese People Living with HIV: 10 years of Post-Marketing Surveillance.. Advances in therapy. https://doi.org/10.1007/s12325-026-03544-0
Source records
- pubmed · retrieved 2026-09-26T18:45:40.292Z